Homoeopathic treatment of irritable bowel syndrome

A mixed-method research to develop diagnostic criteria for tubercular diathesis in homoeopathy and its use in a subsequent double-blind, randomized, placebo-controlled trial evaluating the efficacy of homoeopathic medicines in irritable bowel syndrome - Nil

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/03/064838

Enrollment

Registered

2024-03-27

Start date

Unknown

Completion date

Unknown

Last updated

2024-04-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K582- Mixed irritable bowel syndrome

Interventions

Intervention1: Individualized homeopathic medicines in centesimal medicines plus concomitant care: Intervention is planned as administering indicated homoeopathic remedy in centesimal potencies, as de

dosage and repetition depending upon the individual requirement of the cases. Patients will be advised to refrain from handling the globules or from eating, drinking, smoking or brushing teeth within

dosage and repetition depending upon the individual requirement of the cases. All sundry items will be procured from a Good Manufacturing Practice (GMP) certified firm. All the enrolled patients of bo

Eligibility

Inclusion criteria

Inclusion criteria: 1. Age range: between 18-65 years 2. Either sex or transgender. 3. The patients suffering from IBS (ICD-10- CM K58.0) as per Rome IV diagnostic criteria, i.e., recurrent abdominal pain on average of at least 1 day/ week in the last 3 months associated with either of the following criteria related to defecation, associated with a change in frequency of stool and or associated with a change in form of appearance of stool 4. Patient willingness and written informed consent.

Exclusion criteria

Exclusion criteria: 1. Patients not providing with informed consent voluntarily. 2. Diagnosed cases of unstable psychiatric complaints or systemic diseases affecting quality of life. 3. Major gastro-intestinal surgery in last 6 months 4. For any chronic condition(s), pregnant, lactating and puerperal women 5. Currently ongoing usual standard therapy for IBS 6. Self-reported immune compromised conditions. 7. Substance abuse or dependence. 8. Vulnerable population–Unconscious, non-ambulatory, to oil for consultation, differently abled, terminally ill or critically ill patients, mentally disabled people 9. Undergoing homoeopathic treatment for any chronic disease within last 6months 10. Simultaneous participation in any other clinical trial

Design outcomes

Primary

Measure	Time frame
Irritable Bowel Syndrome Quality of Life Questionnaire (IBS-QOL)Timepoint: Every month up to 3 months	—

Secondary

Measure	Time frame
Irritable Bowel Syndrome Symptom Severity Score(IBS-SSS)Timepoint: Every month up to 3 months;Measure Yourself Medical Outcome Profile (MYMOP2)Timepoint: Every month up to 3 months	—

Countries

India

Contacts

Public ContactRajat Chattopadhyay

The Calcutta Homoeopathic Medical College and Hospital

dr.rajatchatterjee@gmail.com9331041142

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026